Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Opt Soc Am A Opt Image Sci Vis ; 18(6): 1348-56, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11393627

RESUMO

The transformation by a lens of a polychromatic laser beam composed of on-axis superposed monochromatic TEM00 Gaussian modes in the paraxial approximation is studied. The chromatic aberrations are described by allowing the waist position on the z axis and the Rayleigh range to depend on wavelength. The beam radius, the far-field divergence, the Rayleigh range, the beam product, the beam propagation factor, and the kurtosis parameter are calculated. The relationship between the fourth-order and the second-order moments of Hermite-Gaussian and Laguerre-Gaussian modes is obtained and is used for calculating kurtosis parameter. The results are generalized to polychromatic modes of higher orders. It is shown that the on-axis superposition of monochromatic TEM00 modes with no chromatic aberration is leptokurtic.

2.
J Psychopharmacol ; 14(1): 61-6, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10757255

RESUMO

The purpose of this study was to compare the efficacy and tolerability of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia. This was an 8-week, multicentre, randomized, double-blind, parallel-group comparison of venlafaxine and amitriptyline. Outpatients with DSM-IV major depression, a minimum score of 20 on the 21-item Hamilton Depression Rating Scale (HAM-D), and depressive symptoms for at least 1 month were eligible. Patients were randomly assigned to venlafaxine or amitriptyline, both drugs titrated to a maximum of 150 mg/day until study day 15. The primary efficacy variables were the final on-therapy scores on the HAM-D, Montgomery-Asberg Depression Rating Scale and Clinical Global Impression severity scales. Data were evaluated on an intent-to-treat basis using the LOCF method. One hundred and 16 patients were randomized, and 115 were evaluated for efficacy. Both drugs showed efficacy in the treatment of depression with or without melancholia. No significant differences were noted between treatments for any efficacy parameter. However, significantly (p < 0.05) more patients in the amitriptyline group had at least one adverse event. These results should support the efficacy and tolerability of venlafaxine in comparison with amitriptyline for treating major depression with or without melancholia.


Assuntos
Amitriptilina/uso terapêutico , Antidepressivos de Segunda Geração/uso terapêutico , Antidepressivos Tricíclicos/uso terapêutico , Cicloexanóis/uso terapêutico , Transtorno Depressivo Maior/tratamento farmacológico , Transtorno Depressivo/tratamento farmacológico , Adolescente , Adulto , Assistência Ambulatorial , Amitriptilina/efeitos adversos , Antidepressivos de Segunda Geração/efeitos adversos , Antidepressivos Tricíclicos/efeitos adversos , Cicloexanóis/efeitos adversos , Transtorno Depressivo/diagnóstico , Transtorno Depressivo Maior/diagnóstico , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Inventário de Personalidade , Resultado do Tratamento , Cloridrato de Venlafaxina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA